ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
Traws Pharma Inc

Traws Pharma Inc (TRAW)

6,21
-0,49
(-7,31%)
Fermé 17 Février 10:00PM
6,68
0,47
(7,57%)
Après les heures de négociation: 1:59AM

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

Dernier
6,21
Prix Achat
6,10
Prix Vente
6,90
Volume échangé
22 765
6,0201 Fourchette du Jour 6,5682
4,06 Plage de 52 semaines 24,75
Cap du marché
Clôture Veille
6,70
Ouverture
6,568
Dernière Transaction
10
@
6.9
Dernière heure de transaction
Volume financier
US$ 144 080
VWAP
6,329
Volume moyen (3 m)
620 589
Actions en circulation
3 025 554
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-0,99
Bénéfice par action (BPA)
-6,26
Chiffre d'affairess
226k
Bénéfice net
-18,95M

À propos de Traws Pharma Inc

Traws Pharma, Inc., formerly Onconova Therapeutics, Inc., is a virology and oncology company. The Company is engaged in developing antivirals for influenza, COVID and other respiratory infections and narazaciclib. Its proprietary portfolio includes, TRX100 (viroksavir), TRX01 (travaltrevir), and Nar... Traws Pharma, Inc., formerly Onconova Therapeutics, Inc., is a virology and oncology company. The Company is engaged in developing antivirals for influenza, COVID and other respiratory infections and narazaciclib. Its proprietary portfolio includes, TRX100 (viroksavir), TRX01 (travaltrevir), and Narazaciclib. Viroksavir is a cap-dependent endonuclease inhibitor for influenza. Travaltrevir is a Mpro protease inhibitor for COVID19. Narazaciclib is a cyclin-dependent kinases (CDK) 4/6 inhibitor for low-grade endometrioid endometrial cancer (LGEEC). Narazaciclib's mechanism of action in LGEEC is validated by phase II studies with other approved CDK4/6 inhibitors: palbociclib, ribociclib, and abemaciclib. Narazaciclib is in phase I/IIa study to define the Phase II dose (RP2D). Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
Siège social
Wilmington, Delaware, USA
Fondé
-
Traws Pharma Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker TRAW. Le dernier cours de clôture d'Traws Pharma était de US$6,70. Au cours de la dernière année, les actions de Traws Pharma ont été négociées dans une fourchette de prix de US$ 4,06 à US$ 24,75.

Traws Pharma compte actuellement 3 025 554 actions en circulation. La capitalisation boursière d'Traws Pharma est de US$20,27 million. Traws Pharma a un ratio cours/bénéfice (ratio PE) de -0.99.

TRAW Dernières nouvelles

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-2.19-26.07142857148.48.60996.21422857.41084953CS
4-0.58-8.541973490436.798.60995.44553666.88845271CS
121.6636.48351648354.5519.444.0662058911.92589547CS
26-2.665-30.02816901418.87519.444.0630366611.47470399CS
52-18.54-74.909090909124.7524.754.0621905012.13275108CS
156-18.54-74.909090909124.7524.754.0621905012.13275108CS
260-18.54-74.909090909124.7524.754.0621905012.13275108CS

TRAW - Frequently Asked Questions (FAQ)

What is the current Traws Pharma share price?
The current share price of Traws Pharma is US$ 6,21
How many Traws Pharma shares are in issue?
Traws Pharma has 3 025 554 shares in issue
What is the market cap of Traws Pharma?
The market capitalisation of Traws Pharma is USD 20,27M
What is the 1 year trading range for Traws Pharma share price?
Traws Pharma has traded in the range of US$ 4,06 to US$ 24,75 during the past year
What is the PE ratio of Traws Pharma?
The price to earnings ratio of Traws Pharma is -0,99
What is the cash to sales ratio of Traws Pharma?
The cash to sales ratio of Traws Pharma is 83,13
What is the reporting currency for Traws Pharma?
Traws Pharma reports financial results in USD
What is the latest annual turnover for Traws Pharma?
The latest annual turnover of Traws Pharma is USD 226k
What is the latest annual profit for Traws Pharma?
The latest annual profit of Traws Pharma is USD -18,95M
What is the registered address of Traws Pharma?
The registered address for Traws Pharma is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Traws Pharma website address?
The website address for Traws Pharma is www.onconova.com
Which industry sector does Traws Pharma operate in?
Traws Pharma operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
JTAIJet AI Inc
US$ 6,02
(133,33%)
104,48M
SRMSRM Entertainment Inc
US$ 0,6999
(95,50%)
254,39M
WRDWeRide Inc
US$ 31,4877
(83,39%)
21,07M
INLFINLIF Limited
US$ 16,27
(80,58%)
7,68M
MBRXMoleculin Biotech Inc
US$ 2,1201
(66,94%)
136,66M
BLACBellevue Life Sciences Acquisition Corporation
US$ 3,08
(-56,31%)
430,77k
BLACUBellevue Life Sciences Acquisition Corporation
US$ 3,36
(-52,68%)
5,21k
CSAICloudastructure Inc
US$ 19,0001
(-49,58%)
1,03M
NEXNNexxen International Ltd
US$ 10,30
(-49,16%)
164,82k
BSLKBolt Projects Holdings Inc
US$ 0,6626
(-46,13%)
13,4M
CNSPCNS Pharmaceuticals Inc
US$ 0,1415
(31,26%)
489,28M
MGOLMGO Global Inc
US$ 0,7176
(-15,08%)
417,31M
SRMSRM Entertainment Inc
US$ 0,6999
(95,50%)
254,39M
INTCIntel Corporation
US$ 23,60
(-2,20%)
230,26M
NVDANVIDIA Corporation
US$ 138,85
(2,63%)
194,99M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock